Home » Edwards Lifesciences’ CEO Revises Existing Stock Trading Plan
Edwards Lifesciences’ CEO Revises Existing Stock Trading Plan
Edwards Lifesciences Corporation, a global leader in products and technologies to treat advanced cardiovascular disease, announced that its chairman and chief executive officer, Michael A. Mussallem, has revised his existing pre-arranged stock trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934.
News Blaze
News Blaze
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May